Effect of pioglitazone on asthmatic patients
Early Phase 1
Completed
- Conditions
- Asthma.Asthmatic bronchitis NOS Late-onset asthma
- Registration Number
- IRCT201112268528N1
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Inclusion: Asmathic patients; men & women; age range:18-70 years
Exclusion: Heart failure; active liver disease including high level of liver enzymes; Edema; Hypersensitivity to pioglitazone; serious drug side effects and/or drug interactions during intervention
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary function. Timepoint: before intervention and at the end of it ( 2 months later). Method of measurement: Spirometry test.
- Secondary Outcome Measures
Name Time Method Inflammatory biomarkers including TNF alpha And interlukins. Timepoint: before intervention and post intervention (2 months after) ). Method of measurement: quantitative kits with ELIZA reader.